| |
Newly diagnosed HIV cases, n %
|
Univariate analysis
|
Multivariable analysis (n = 10,257)
|
|---|
|
Factor
|
total with DSS/DPS4
|
with recent infection
|
OR*
|
95% CI°
|
OR*
|
95% CI°
|
|
Total
|
10,257
|
100%
|
3,084
|
30.01%
| | | | |
|
Gender
|
|
Men
|
8,541
|
83.3%
|
2,705
|
31.7%
|
(ref)
| |
(ref)
| |
|
Women
|
1,716
|
16.7%
|
379
|
22.1%
|
0.61#
|
0.54–0.69
|
0.94
|
0.79–1.12
|
|
Region of origin
|
|
Germany
|
6,405
|
62.5%
|
2,121
|
33.1%
|
(ref)
| |
(ref)
| |
|
Abroad
|
2,853
|
27.8%
|
673
|
23.6%
|
0.62#
|
0.56–0.69
|
0.74#
|
0.66–0.84
|
|
Unknown
|
999
|
9.7%
|
290
|
29.0%
|
0.83##
|
0.71–0.96
|
0.94
|
0.80–1.11
|
|
Age group
|
|
< 25 years
|
1,216
|
11.9%
|
523
|
43.0%
|
(ref)
| |
(ref)
| |
|
25–34 years
|
3,443
|
33.6%
|
1,091
|
31.7%
|
0.61#
|
0.54–0.70
|
0.63#
|
0.55–0.72
|
|
35–44 years
|
2,986
|
29.1%
|
846
|
28.3%
|
0.52#
|
0.46–0.60
|
0.53#
|
0.46–0.61
|
|
45–54 years
|
1,838
|
17.9%
|
470
|
25.6%
|
0.46#
|
0.39–0.53
|
0.45#
|
0.39–0.53
|
|
> =55 years
|
774
|
7.5%
|
154
|
19.9%
|
0.33#
|
0.27–0.41
|
0.35#
|
0.28–0.43
|
|
Mode of transmission
|
|
MSM1
|
5,993
|
58.4
|
2,095
|
35.0%
|
(ref)
| |
(ref)
| |
|
HET2
|
1,909
|
18.6
|
393
|
20.6%
|
0.48#
|
0.43–0.55
|
0.65#
|
0.54–0.79
|
|
IDU3
|
307
|
3.0
|
107
|
34.9%
|
1.00
|
0.78–1.27
|
1.18
|
0.92–1.51
|
|
Unknown
|
2,048
|
20.0
|
489
|
23.9%
|
0.58#
|
0.52–0.65
|
0.68#
|
0.60–0.77
|
|
Region of presumed infection
|
|
Germany
|
7,124
|
69.4%
|
2,346
|
32.9%
|
(ref)
| |
(ref)
| |
|
Abroad
|
1,803
|
17.6%
|
387
|
21.5%
|
0.56#
|
0.49–0.63
|
0.85##
|
0.73–0.99
|
|
Unknown
|
1,330
|
13.0
|
351
|
26.4%
|
0.73#
|
0.64–0.83
|
0.98
|
0.84–1.14
|
-
1MSM: men who have sex with men
-
2IDU: persons who are intravenous drug users
-
3HET: persons with heterosexual contact
-
4 DSS/DPS: Dried Serum Spot/Dried Plasma Spot
-
*OR: odds ratio
-
°95% CI: 95% Confidence interval
- # p-value: p < =0.001
- ## p-value: p < =0.05
